%20(15)_edited.png)
Taking care of your health since 1985
For over three decades, we've been more than just a healthcare provider, we’ve been a trusted partner in your journey to wellness. Since 1985, our mission has been simple: to offer compassionate, reliable, and expert care tailored to every individual. From preventive checkups to specialized treatments, we’ve evolved with time, but our commitment remains unchanged, your health, our priority.
Number 1 Medical Clinic in the Central India
The only 3 Tesla MRI Siemens Lumina in Nagpur
CGHS Beneficiaries Accepted
NABH Accredited Centre
Ga‑68 PSMA PET:
A cutting‑edge scan for high‑sensitivity detection and staging of prostate cancer, enabling more accurate localization of recurrent or metastatic disease and guiding targeted therapy decisions.
Ga‑68 DOTANOC PET:
The gold‑standard molecular imaging for neuroendocrine tumors (NETs), improving detection of primary and metastatic NET lesions and assisting in selection and monitoring of peptide receptor radionuclide therapy (PRRT).
Ga-68 FAPI PET-CT
Advanced molecular imaging for highly sensitive detection of multiple cancers with excellent tumor visualization and low background activity. Particularly useful in staging, recurrence detection, and therapy planning.
Ga-68 Exendin-4 PET-CT (Insulinoma Imaging)
Specialized PET imaging for accurate localization of insulinomas and small pancreatic neuroendocrine tumors causing hypoglycemia. Helps guide precise surgical planning and treatment.
Ga-68 Trivehexin PET-CT
Novel integrin-targeted imaging used for assessing tumor angiogenesis and aggressive 56tumor biology. Useful in advanced oncology imaging and therapy response evaluation.
Ga-68 CXCR4 PET-CT
Advanced receptor-targeted PET imaging for hematological malignancies including lymphoma, leukemia, and multiple myeloma. Supports precision oncology and theranostic applications.Real‑time PET/CT‑guided Biopsies: an advanced precision oncology service that shortens procedure time, lowers false‑negative rates, and increases pathologist confidence by targeting metabolically active tissue.
